Diagnosis and therapy of Alzheimer's disease: Light-driven heterogeneous redox processes.
Adv Colloid Interface Sci
; 332: 103253, 2024 Oct.
Article
en En
| MEDLINE
| ID: mdl-39067260
ABSTRACT
Light-driven heterogeneous processes are promising approaches for diagnosing and treating Alzheimer's disease (AD) by regulating its relevant biomolecules. The molecular understanding of the heterogeneous interface environment and its interaction with target biomolecules is important. This review critically appraises the advances in AD early diagnosis and therapy employing heterogeneous light-driven redox processes, encompassing photoelectrochemical (PEC) biosensing, photodynamic therapy, photothermal therapy, PEC therapy, and photoacoustic therapy. The design strategies for heterogeneous interfaces based on target biomolecules and applications are also compiled. Finally, the remaining challenges and future perspectives are discussed. The present review may promote the fundamental understanding of AD diagnosis and therapy and facilitate interdisciplinary studies at the junction of nanotechnology and bioscience.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Oxidación-Reducción
/
Enfermedad de Alzheimer
Idioma:
En
Revista:
Adv Colloid Interface Sci
Asunto de la revista:
QUIMICA
Año:
2024
Tipo del documento:
Article